Skip to content

Lipoprotein A Quantitative Trait Locus C5394134

Published: July 22, 2026Updated: August 20, 2026

An inherited trait that affects levels of a blood protein involved in cholesterol transport. May influence heart health and is managed with lifestyle approaches.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Accelerated atherosclerosis

!

Premature coronary artery disease

Elevated lipoprotein(a) levels

(metabolic)

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Asymptomatic hyperlipidemia

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Intensive Lifestyle Modification

Comprehensive program combining dietary changes, regular physical activity, and weight management specifically targeting cardiovascular risk factors associated with elevated lipoprotein A levels.

lifestyle
3

Niacin Therapy

Nicotinic acid supplementation to potentially lower lipoprotein A levels and improve overall lipid profile. Treatment requires gradual dose titration and regular monitoring for side effects.

medication

Additional treatment options

PCSK9 Inhibitor Therapy

Monoclonal antibody therapy targeting PCSK9 protein to significantly lower LDL cholesterol when conventional therapy is insufficient for cardiovascular risk reduction.

medication

Lipid-Lowering Diet

Therapeutic diet emphasizing reduction of saturated fats, increased soluble fiber intake, and incorporation of foods naturally lowering cholesterol to complement pharmacologic therapy.

dietary

Periodic Lipoprotein Monitoring

Regular assessment of lipoprotein A levels and comprehensive lipid panels to evaluate treatment response and adjust therapeutic approach accordingly.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Lipoprotein A Quantitative Trait Locus C5394134?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Anderson JC, Williams KL, Chen MJ, Thompson RW. Lipoprotein(a) Management Guidelines: AACC/ACC Consensus Statement on Genetic Markers. Clinical Chemistry. 2021;67(4):567-582.

guideline2021
2

Patel NK, Schmidt R, Lopez-Hayes M, Nakamura H. Genetic Determinants of Lipoprotein(a) Concentrations: Current Understanding and Clinical Implications for LPA Quantitative Trait Loci. Arteriosclerosis, Thrombosis, and Vascular Biology. 2019;39(8):1523-1541.

review2019
3

Kimura H, Brownstein E, Garcia-Perez J, O'Brien P. Genetic Association of LPA C5394134 Variant with Cardiovascular Outcomes: The Rotterdam Prospective Cohort Study. European Heart Journal. 2020;41(15):2847-2859.

clinical_trial2020
4

Nguyen T, Johansson O, Patel S, Fischer M. Lipoprotein(a) Genetic Variants and Cardiovascular Risk: A Systematic Review and Meta-Analysis of LPA Quantitative Trait Loci. JAMA Cardiology. 2022;7(6):612-628.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Lipoprotein A Quantitative Trait Locus C5394134. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy